RT Journal Article
SR Electronic
T1 Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature.
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP jnmt.121.261979
DO 10.2967/jnmt.121.261979
A1 Kumar, Munish
A1 Subramanian, Karthikeyan
A1 Tanwar, Karan Singh
A1 Prabhahar, Arun
A1 Divyaveer, Smita
A1 Sood, Ashwani
A1 Mittal, Bhagwant Rai
A1 Sood, Apurva
YR 2021
UL http://tech.snmjournals.org/content/early/2021/12/06/jnmt.121.261979.abstract
AB Surgical resection followed by radioactive-iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer (DTC). 131I is normally excreted through kidneys and treatment of patients with end stage renal disease (ESRD) on hemodialysis requires special attention for dosage of 131I, timing of dialysis and radiation safety. We present a case of a post-thyroidectomy patient with ESRD on haemodialysis who required radioactive iodine ablation with review of literature.